Progress in pulmonary medicine in several areas has been limited by an incomplete understanding of basic mechanisms of the pathogenesis of disorders such as chronic obstructive pulmonary disease (COPD), asthma, acute lung injury and the adult respiratory distress syndrome, tuberculosis, interstitial lung disease (including idiopathic pulmonary fibrosis), and lung cancer. In the past few years however, advances in basic science have brought a greater understanding of some of the processes likely to be involved in these diseases, and advances in basic investigative techniques such as genomics and proteomics, hold promise for broad application in clinical medicine. Crucial to the application of advances in basic science to important problems in clinical pulmonary medicine will be the development of a cadre of physician-scientists with an both an understanding of relevant basic science and lung biology as well as the tools to apply that knowledge in the clinical setting in order to carry our rigorous translational studies in lung disease that can test and confirm hypotheses developed at the bench, with the ultimate goal of developing potent new therapeutic approaches for a variety of disorders. Our goal in this application is consistent with that set forth by NIH itself in its introduction of career development awards for young investigators with an interest in clinical or patient oriented research: """"""""to encourage research-oriented clinicians to develop independent research skills and gain experience in advanced methods and experimental approaches needed to conduct patient-oriented research."""""""" The training program described in this application will enable trainees to successfully apply for these NIH-sponsored career development awards, or their equivalent. The rationale behind the establishment of this training program is a follows: 1. There is a manifest need to prepare physician-scientists to conduct translational research in pulmonary medicine. 2. As basic science research reaches this translational stage, it will be important to Wain individuals to develop an integrated understanding of a variety of processes in cell biology, immunology, genetics, molecular biology, clinical research, epidemiology, and clinical medicine. 3. The College of Physicians and Surgeons of Columbia University and the Columbia Presbyterian Medical Center provide an outstanding environment for a comprehensive and integrated training program in pulmonary translational research, owing to the depth and breadth of basic and clinical academic programs at the institutions. 4. By providing formal didactic instruction, mentoring, and well-structured research opportunities, the program will attract basic and clinical scientist trainees who wish to receive rigorous training in the area of pulmonary translational research.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
1T32HL072739-01A1
Application #
6749391
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2004-04-01
Project End
2009-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
1
Fiscal Year
2004
Total Cost
$123,716
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Singer, Jonathan P; Peterson, Eric R; Snyder, Mark E et al. (2014) Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med 190:1012-21
Flores, Marcella; Desai, Dharmesh D; Downie, Matthew et al. (2009) Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells. J Immunol 183:7129-39
Liang, Bitao; Workman, Craig; Lee, Janine et al. (2008) Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 180:5916-26
Lederer, David J; Horn, Evelyn M; Rosenzweig, Erika B et al. (2008) Plasma serotonin levels are normal in pulmonary arterial hypertension. Pulm Pharmacol Ther 21:112-4
Yegen, Hilary A; Lederer, David J; Barr, R Graham et al. (2007) Risk factors for venous thromboembolism after lung transplantation. Chest 132:547-53
Harbers, Stephanie O; Crocker, Andrea; Catalano, Geoffrey et al. (2007) Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest 117:1361-9
Desai, Dharmesh D; Harbers, Stephanie O; Flores, Marcella et al. (2007) Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J Immunol 178:6217-26
Lederer, David J; Thomashow, Byron M; Ginsburg, Mark E et al. (2007) Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year. J Thorac Cardiovasc Surg 133:1434-8
Lederer, David J; Arcasoy, Selim M; Wilt, Jessie S et al. (2006) Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174:659-64
Lederer, D J; Arcasoy, S M; Barr, R G et al. (2006) Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis. Am J Transplant 6:2436-42